MRNA Wins FDA Panel Backing
Moderna's mRNA flu vaccine benefits outweigh the risks in adults aged 65 and above
MRNA - MODERNA WINS FDA PANEL BACKING FOR MRNA FLU VACCINE -- BENEFITS OF MODERNA'S FLU VACCINE OUTWEIGH THE RISKS IN ADULTS AGED 65 AND ABOVE (SM Circulations)